Venus Remedies’ Meropenem receives market authorisation in Mexico
Plans to launch its first product in the market within the first quarter of fiscal year 2014
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Big R&D investment trend as mid-cap biotechs push to get drugs to market
Peer group R&D spend for Q3 2012 reached $746.8 million, climbing from $621.1 million in Q3 2011
SMT deploys Verint Systems’ Nextiva video and situation intelligence solutions
Nextiva solution helps SMT adhere to compliance and quality standards, as well as enhance overall operational efficiency
India is making slow progress in advancing women in science and technology: Study
Numbers of women in engineering, physics and computer science on the decline
Is negotiated price a reasonable price?
Is Section 84(1)(b) of The Patents Act of India in danger? A scrupulous analysis by Milind Sathe
Proud feeling to read interviews of women
Dear Express Pharma Team, Referring to the latest Express Pharma issue (March 1-15, 2013: International Women's Day special), it’s…
Frank Heinricht appointed Chairman of the Board of Management of SCHOTT
Will join office on June 1, 2013
Ranbaxy to market depressive disorder tabs in the US
Enters into an in-licensing business agreement with Alembic
Sequestration cuts set to see US healthcare funding slashed
Cuts could threaten the future of medical research: GlobalData analysis